Laboratory manipulation of the AIDS-causing virus reveals evolutionary ‘dead-ends’
June 1, 2017
| By Rachel Tompa / Fred Hutch News Service
Fred Hutch researchers have created a library containing millions of mutant HIV viruses. Some of these mutants are very good at infecting human cells, no different from their “natural” viral ancestor. Some of them are worse. Together, they can teach researchers something important about HIV in humans.
Dr. Leo Stamatatos gets funding to manufacture, test first Hutch-developed HIV vaccine candidate; Dr. Lu Chen authors largest study yet to examine breast cancer disparities; Dr. Amit Sharma wins Foundation for AIDS Research (amfAR) award; Dr. Harlan Robins of Adaptive Technologies among ‘100 Most Intriguing Entrepreneurs’
Researchers describe a way to induce long-sought broadly neutralizing antibodies
Dec. 11, 2014
| By Mary Engel / Fred Hutch News Service
A new study, published today in the journal Science, suggests why previous HIV vaccine formulations haven’t been able to elicit broadly neutralizing antibodies, which defend against a wide spectrum of HIV strains.
Fred Hutch is proud to be an Equal Opportunity and VEVRAA Employer. We are committed to cultivating a workplace in which diverse perspectives and experiences are welcomed and respected. We do not discriminate on the basis of race, color, religion, creed, ancestry, national origin, sex, age, disability, marital or veteran status, sexual orientation, gender identity, political ideology, or membership in any other legally protected class. We are an Affirmative Action employer. We encourage individuals with diverse backgrounds to apply and desire priority referrals of protected veterans. Read the EEO is the Law poster here.